Literature DB >> 16434659

Natural history of Type A Niemann-Pick disease: possible endpoints for therapeutic trials.

M M McGovern1, A Aron, S E Brodie, R J Desnick, M P Wasserstein.   

Abstract

OBJECTIVE: To describe the disease course and natural history of Type A Niemann-Pick disease (NPD).
METHODS: Ten patients with NPD-A (six male, four female; age range at entry: 3 to 6 months) were serially evaluated including clinical neurologic, ophthalmologic, and physical examinations, and assessment of development. Laboratory analyses, abdominal and brain ultrasounds, and chest radiographs also were obtained and information on intercurrent illnesses and cause of mortality was collected.
RESULTS: All affected infants had a normal neonatal course and early development. The first symptom detected in all patients was hepatosplenomegaly. Developmental age did not progress beyond 10 months for adaptive behavior, 12 months for expressive language, 9 months for gross motor skills, and 10 months for fine motor skills. Non-neurologic symptoms included frequent vomiting, failure to thrive, respiratory infections, irritability, and sleep disturbance. Neurologic examination at the time of presentation was normal in most patients. Later neurologic examinations revealed progressive hypotonia with loss of the deep tendon reflexes. All patients had cherry red spots by 12 months. The median time from diagnosis to death was 21 months. The cause of death was respiratory failure in nine patients and complications from bleeding in the tenth.
CONCLUSIONS: The clinical course in Type A Niemann-Pick disease is similar among affected patients and is characterized by a relentless neurodegenerative course that leads to death, usually within 3 years.

Entities:  

Mesh:

Year:  2006        PMID: 16434659     DOI: 10.1212/01.wnl.0000194208.08904.0c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Two siblings with Niemann-Pick disease (NPD) type B: clinical findings and novel mutations of the acid sphingomyelinase gene.

Authors:  Zoran Gucev; Velibor Tasic; Nada Pop-Jordanova; Aleksandra Jancevska; Calogera M Simonaro; Edward H Schuchmann
Journal:  Indian J Pediatr       Date:  2012-02-25       Impact factor: 1.967

2.  Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B.

Authors:  Melissa Wasserstein; James Godbold; Margaret M McGovern
Journal:  J Inherit Metab Dis       Date:  2012-06-21       Impact factor: 4.982

Review 3.  Damage control: cellular mechanisms of plasma membrane repair.

Authors:  Norma W Andrews; Patricia E Almeida; Matthias Corrotte
Journal:  Trends Cell Biol       Date:  2014-08-20       Impact factor: 20.808

4.  Niemann-Pick disease resulting in spontaneous splenic rupture in an adult: report of a case.

Authors:  Zihua Chen; Zhikang Chen; Shaobin Wu; Xianwei Wang
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

5.  Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.

Authors:  Melissa P Wasserstein; Simon A Jones; Handrean Soran; George A Diaz; Natalie Lippa; Beth L Thurberg; Kerry Culm-Merdek; Elias Shamiyeh; Haig Inguilizian; Gerald F Cox; Ana Cristina Puga
Journal:  Mol Genet Metab       Date:  2015-05-30       Impact factor: 4.797

6.  Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase.

Authors:  Xiang Li; Erich Gulbins; Yang Zhang
Journal:  Cell Physiol Biochem       Date:  2012-08-10

Review 7.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

Review 8.  Roles and regulation of secretory and lysosomal acid sphingomyelinase.

Authors:  Russell W Jenkins; Daniel Canals; Yusuf A Hannun
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

9.  Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.

Authors:  Na Lin; Huiwen Zhang; Wenjuan Qiu; Jun Ye; Lianshu Han; Yu Wang; Xuefan Gu
Journal:  J Lipid Res       Date:  2013-11-04       Impact factor: 5.922

10.  Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients.

Authors:  Laura Rodríguez-Pascau; Laura Gort; Edward H Schuchman; Lluïsa Vilageliu; Daniel Grinberg; Amparo Chabás
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.